StockGlow

Alkermes plc (8AK.F)

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

43.26+0.03%Healthcare
Compare 8AK.F with
StockGlow Score
89
Bullish
BearishBullish
1 year ago+91.4%

The outlook

Alkermes plc currently reads as bullish based on above its 50- & 200-day averages, 81% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range81% of the way from its 52-week low to high
Market cap
$7.26B
52-wk high
48.19
52-wk low
22.00
50-day avg
41.28
200-day avg
30.19
Trailing P/E
131.1

Similar stocks

2L9.FVisionWave Holdings, Inc.$1.63-4.13%RV7.FHalozyme Therapeutics, Inc.$72.16-0.39%NB3.FNeurocrine Biosciences, Inc.$145.00-7.73%ICY.FIncyte Corporation$107.20-2.85%DR6.FACADIA Pharmaceuticals Inc.$23.02+0.61%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy